Text Size
16 studies found for:    Tropical Spastic Paraparesis

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
Condition: Tropical Spastic Paraparesis
Intervention:
2 Active, not recruiting Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Tamibarotene
3 Recruiting Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Condition: HTLV-1
Intervention: Drug: Hu MiK-Beta-1
4 Completed Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)
Conditions: HTLV-I Infection;   Spinal Cord Disease;   Tropical Spastic Paraparesis
Intervention: Drug: Recombinant human interferon beta-1a
5 Completed A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis
Condition: HTLV-I
Intervention:
6 Completed Zidovudine Plus Lamivudine in HTLV-I-Associated Myelopathy: a Randomised Trial
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Zidovudine/lamivudine
7 Recruiting Evaluation of Patients With HAM/TSP
Conditions: HTLV-I Infection;   Tropical Spastic Paraparesis
Intervention:
8 Completed Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Condition: HTLV I Associated Myelopathy
Intervention: Drug: ciclosporin
9 Enrolling by invitation Urological Physical Therapy in HTLV-1 With Urinary Symptoms
Conditions: Tropical Spastic Paraparesis;   HTLV-1
Intervention: Procedure: Urological physical therapy
10 Active, not recruiting Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases
Conditions: HTLV-1;   Tropical Spastic Paraparesis;   Immune System Diseases;   Physical Disability;   Pentoxifylline
Interventions: Drug: Pentoxifylline;   Drug: Placebo
11 Completed Assessment of Patients With Multiple Sclerosis (MS)
Conditions: Herpesviridae Infection;   HTLV-I Infection;   Multiple Sclerosis;   Tropical Spastic Paraparesis;   Vasculitis
Intervention:
12 Unknown † Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)
Condition: Paraparesis Spastic Tropical
Interventions: Drug: Valproic acid;   Drug: costicosteroids;   Drug: valproid acid plus corticosteroids
13 Terminated The HAM Infliximab Study
Condition: HTLV-I-associated Myelopathy
Intervention: Drug: Infliximab
14 Not yet recruiting Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1
Condition: HTLV-I Infections
Intervention:
15 Enrolling by invitation Evaluation of the MP Diagnostics HTLV Blot 2.4
Conditions: HTLV-I Infections;   HTLV-II Infections;   Human T-lymphotropic Virus 1;   Human T-lymphotropic Virus 2;   HTLV I Associated T Cell Leukemia Lymphoma;   HTLV I Associated Myelopathies
Intervention: Other: CDPHL Algorithm
16 Terminated Safety and Efficiency Study of Valproic Acid In HAM/TSP
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Valproic Acid
To Top

† Indicates status has not been verified in more than two years